EastWest Bioscience Inc.
HBOSF · OTC
7/31/2021 | 7/31/2020 | 7/31/2019 | |
|---|---|---|---|
| Revenue | $627 | $923 | $1,397 |
| % Growth | -32% | -34% | – |
| Cost of Goods Sold | $599 | $821 | $1,041 |
| Gross Profit | $28 | $101 | $356 |
| % Margin | 4.5% | 11% | 25.5% |
| R&D Expenses | $11 | $3 | $7 |
| G&A Expenses | $2,377 | $1,827 | $3,378 |
| SG&A Expenses | $2,225 | $1,878 | $3,488 |
| Sales & Mktg Exp. | $100 | $50 | $110 |
| Other Operating Expenses | $0 | -$14 | -$61 |
| Operating Expenses | $2,249 | $1,911 | $3,626 |
| Operating Income | -$2,221 | -$1,810 | -$3,270 |
| % Margin | -354% | -196.2% | -234.1% |
| Other Income/Exp. Net | $8 | $155 | -$705 |
| Pre-Tax Income | -$1,640 | -$1,109 | -$3,657 |
| Tax Expense | -$33 | $23 | $10 |
| Net Income | -$1,607 | -$1,132 | -$3,667 |
| % Margin | -256.2% | -122.7% | -262.5% |
| EPS | -0.017 | -0.014 | -0.046 |
| % Growth | -25.7% | 70.8% | – |
| EPS Diluted | -0.017 | -0.014 | -0.046 |
| Weighted Avg Shares Out | 94,729 | 83,771 | 79,089 |
| Weighted Avg Shares Out Dil | 94,729 | 83,771 | 79,089 |
| Supplemental Information | – | – | – |
| Interest Income | $0 | $0 | $0 |
| Interest Expense | $257 | $223 | $259 |
| Depreciation & Amortization | $119 | $127 | $136 |
| EBITDA | -$1,649 | -$1,731 | -$3,134 |
| % Margin | -262.9% | -187.6% | -224.4% |